Pharm-Olam's US Government Federal Research Services (USGFRS) group is dedicated to providing full-service contracting and clinical development support to sponsors seeking and using government funding for Phase I-IV drug and vaccine research.
Our team has over 20 years' experience in contracting and conducting federally funded drug and vaccine research. We have worked with a wide variety of US government agencies such as the National Institutes of Health (NIH), Department of Defense (DOD), Biomedical Advanced Research and Development (BARDA), Defense Health Agency (DHA), and Centers for Disease Control and Prevention to name a few. Additionally, our team has experience collaborating with non-government organizations (NGOs) and non-profit organizations (NPOs).
Over the past decade, Pharm-Olam’s US Government Federal Research Service team has worked on a portfolio of more than $778M in federally funded clinical trials. Pharm-Olam is poised as mid-size global CRO to support the unique demands of your next federally funded clinical trial. Learn more about our services below.
With a team of seasoned US Government researchers on staff, and with staffed offices in 29 countries (monitoring trials in 60+ countries), Pharm-Olam pairs the same personalized, detail-driven attention one would expect of an in-house development team with one of the largest full-time and permanent global coverage networks in the mid-tier CRO category.
Our team respects exactly how much is at stake wherever public funding is involved. In particular, we know just what government-sponsored therapeutic research expects: evidence-based results with reduced risks, controlled clinical program costs and shortened time-to-market.
We specialize in identifying government funded opportunities. As part of our standard service offering, we meet with officials and qualify opportunities on your behalf.
Our team will form persuasive proposals that are compliant with government regulations and Sunshine laws. We also provide assistance and services that can help sponsors write technical narratives, and distill announcements/RFPs.
In the final rounds of contention, our team will advocate for your best interests, negotiate contract terms and conditions, and create flow-down clauses for subcontractors and vendors.
We ensure that projects comply with all applicable federal regulations. We are well versed in Federal Acquisition Regulations, as well as DFAR, HHSAR and ITAR.
Pharm-Olam’s use of the Earned Value Management (EVM) system ensures study sponsors that our teams employ systematic planning and project oversight, we thereby make sure our clients meet strict reporting and regulatory requirements, through: